Navigation Links
NW BIO ANNOUNCES PRICING OF $17.5 MILLION OFFERING OF CONVERTIBLE NOTES
Date:8/14/2014

BETHESDA, Md., Aug. 14, 2014 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio") today announced the pricing of $17.5 million aggregate principal amount of its unsecured convertible notes (the "Notes") in a private placement.  The Notes are initially convertible at $7.30 per share, a 10% premium above the closing market price of $6.64 per share on August 13, 2014.  NW Bio plans to use the offering proceeds to fund new manufacturing capacity in Europe and for general corporate purposes.

The Notes will bear interest at a rate of 5.00% per year, and mature in three years unless earlier converted.  The Notes will be subject to certain adjustments as provided in the Indenture. The investors in the Notes will have the right, exercisable for three months, to purchase up to an additional 30% of the aggregate principal amount of the Notes on the same terms and conditions. 

The sale of the Notes to the initial purchasers is expected to settle on August 19, 2014, subject to customary closing conditions, and is expected to result in approximately $16.15 million net proceeds to NW Bio, after deducting fees and estimated offering expenses payable by NW Bio.  

Neither the Notes nor the shares of NW Bio's common stock issuable upon conversion of the Notes, if any, have been registered under the Securities Act of 1933, as amended (the "Act") or the securities laws of any other jurisdiction, and may not be offered or sold in the United States absent registration or an applicable exemption from such registration requirements.  This press release does not constitute an offer to sell, or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale is un
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vermillion Announces Additions to Commercial Management Team
2. Immune Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Update on Bertilimumab Commencement of Phase II Clinical Trials
3. Veracyte, Inc. Announces Second Quarter 2014 Financial Results
4. Hanger Announces Appointment of Asif Ahmad to Board of Directors
5. BiOptix Announces Additional $1.4M in Funding to Aid in Commercialization and Working Capital Needs
6. Perrigo Company plc Announces Quarterly Dividend
7. Kindred Biosciences Announces Second Quarter 2014 Financial Results
8. Imprimis Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Operational Update
9. WuXi PharmaTech Announces Second-Quarter 2014 Results
10. Nutrastar International Inc. Announces Second Quarter 2014 Results
11. Novogen Announces Results of General Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), a ... blood purification technology to help fight deadly inflammation ... countries worldwide, today announced the appointment of Dr. ... as its Senior Vice President of Clinical Development, ... Di Russo is an accomplished pediatric ...
(Date:12/22/2014)... , Dec. 22, 2014   TRU-D SmartUVC ... no-touch UV disinfection robot, announced today that the General ... contract through November 2019.   This newly ... engage all levels of government purchasers, including Department of ... well as Homeland Security contacts purchasing solutions for the ...
(Date:12/22/2014)... STOCKHOLM , Dec. 22, 2014 Swedish ... Inc. today announced that the Committee for Medicinal Products ... (EMA) has adopted a positive opinion for the use ... adult men with Peyronie,s disease with a palpable plaque ... the start of therapy. The use of ...
Breaking Medicine Technology:CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6
... SEELZE, Germany, Dec. 3 Honeywell (NYSE: ... Pro-Lab Laboratuar Teknolojileri, which will distribute Honeywell,s Burdick & ... solvents are used extensively by biotechnology and pharmaceutical companies ... annual growth rate of the Turkish pharmaceutical market is ...
... , JERSUSALEM and NEEDHAM, ... ORIDN) today announced that the Bavarian Red Cross has chosen ... use of capnography can help paramedic teams to assess the ... to issues that affect respiratory status such as displaced endotracheal ...
Cached Medicine Technology:Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 2Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 2Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 4
(Date:12/25/2014)... 25, 2014 The short film “Color of ... in honor of a true 9/11 hero, Welles Remy Crowther. ... including the 24 hours of Nuremberg International Short Film Festival ... , Actress, screenwriter and director Luciana Lagana plays ... together with her husband, Gregory Graham - Graham ...
(Date:12/25/2014)... FL (PRWEB) December 25, 2014 When head ... find themselves in a frenzy to get rid of it ... But families in Coral Gables now have the solution right ... second salon clinic location, Lice Troopers provides full spectrum head ... the Coral Gable area, including Sunset, Key Biscayne, Brickell, Coconut ...
(Date:12/25/2014)... THURSDAY, Dec. 25, 2014 (HealthDay News) -- Overeating is common ... you eat in moderation, an expert says. "Don,t arrive ... up calories if you know you,ll be attending a party, ... Jill Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount ... better to eat healthy during the day and even to ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... ) continue to move forward in a number of ... District of West Virginia, Bernstein Liebhard LLP reports. According ... Court is scheduled to convene a Joint Status Conference ... at 10:00 a.m. Parties have been directed to submit ...
(Date:12/25/2014)... Each year trauma accounts for approximately ... admissions across the nation (according to the Centers ... National Hospital Ambulatory Medical Care Survey collected data ... 2010. They estimated that there were between 3.5 and ... primary diagnosis of broken bone or fracture. , ...
Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4
... In the racy television hit show, Sex and the City, ... that "Men who are too good looking are never good ... just one of the many gender stereotypes that audiences were ... about sex and gender and refrained from the gender caricatures ...
... set up in London to bring the Cinderella area of medicine ... million centre of excellence has just begun at Queen Mary, University ... The aim is to fast-track new operations for bowel ... out to hospitals all over the UK. The NCBRSI ...
... Antiviral drugs used to target the herpes virus could be ... new study shows. The University of Manchester scientists have ... is a risk factor for Alzheimer,s when it is present ... risk to the disease. AD is an incurable neurodegenerative ...
... , MONDAY, Oct. 17 (HealthDay News) -- ,Fast ... the same vehicle are among the reasons why thousands of ... according to new research. The findings were to be ... Conference and Exhibition in Boston. According to the AAP, ...
... By Randy Dotinga HealthDay Reporter , MONDAY, ... into fountains of four-letter words? Maybe so, says a new ... profanity-ridden shows and video games. However, the research ... swearing among kids, nor does it explain why non-aggressive cussing ...
... children who live in a home with a swimming pool ... death among toddlers. A study abstract presented Monday, Oct. 17, ... Exhibition in Boston identifies three likely scenarios that precede the ... in an at-home swimming pool. In the study, "Patterns ...
Cached Medicine News:Health News:Women, men and the bedroom 2Health News:New national research center for bowel disease in London will be a UK first 2Health News:New national research center for bowel disease in London will be a UK first 3Health News:New national research center for bowel disease in London will be a UK first 4Health News:Antiviral drugs may slow Alzheimer's progression 2Health News:Too Many Kids Injured in ATV Crashes, Study Finds 2Health News:Profanity on TV Linked to Foul-Mouthed Kids 2Health News:Study identifies scenarios that precede at-home pool drownings of young children 2
... NCP-1, was designed to maximize patient comfort ... the first ever to feature Vacuum Pump ... augmentation and reduces the "slamming" effect commonly ... treatment platform maintains patients comfort and security ...
... The Arctic Sun 2000 represents a ... The Arctic Sun System rapidly induces mild ... from therapeutic hypothermia or rapidly reduces temperature ... monitors and maintains core body temperature in ...
... Artic Sun 100 monitors and controls patient ... hypothermia associated with surgery, trauma, or other ... response to feedback provided from a patient ... ambient (room air) and 42C (107.6F) to ...
... its professional AED offeringthe G3 Pro. ... ECG color display, provides manual override ... most advanced technology available to provide ... for emergency treatment of sudden cardiac ...
Medicine Products: